Stay updated on HMPL-523 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.

Latest updates to the HMPL-523 in Hematologic Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s displayed system revision/version has been updated from v3.5.2 to v3.5.3, reflecting a technical update to the ClinicalTrials.gov interface rather than changes to the study information itself.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded IQVIA Pty Ltd as a collaborator in the Collaborators and Investigators section and removed the misspelled entry 'Iqvia Pty Ltd' to correct the collaborator list.SummaryDifference0.1%

- Check51 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; this appears to be an administrative update rather than a change to the trial details.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. No user-visible content changes detected in the screenshots.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to HMPL-523 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.